Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06925607

Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis

A Phase l Clinical Study Evaluating the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
6 (estimated)
Sponsor
Jiangsu Topcel-KH Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A Phase l clinical study evaluating the distribution and dynamic behavior of Nuclide labeled TH-SC01 cells in vivo in patients with Radiation proctitis

Conditions

Interventions

TypeNameDescription
DRUGMesenchymal Stem Cells (MSCs)single dose injection (120 million cells)

Timeline

Start date
2025-04-01
Primary completion
2026-03-01
Completion
2026-12-01
First posted
2025-04-13
Last updated
2025-04-13

Source: ClinicalTrials.gov record NCT06925607. Inclusion in this directory is not an endorsement.